Find out more about Anastasia Chrysostomou's experience
Anastasia Chrysostomou's highlights
Anastasia Chrysostomou's selected work
Increasing Prevalence and Risk of Chronic Kidney Disease in Human Immunodeficiency Virus-I..
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonis..
Lymphocytic hypophysitis: a rare cause of hypoglycaemia in a man with type 2 diabetes mell..
Displaying the 9 most recent scholarly works by Anastasia Chrysostomou.
Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus
FB Vincent, R Kandane-Rathnayake, AY Hoi, L Slavin, JD Godsell, AR Kitching, J Harris, CL Nelson, AJ Jenkins, A Chrysostomou, ML Hibbs, PG Kerr, M Rischmueller, F Mackay, EF Morand
Journal article | 2018 | Lupus
Increasing Prevalence and Risk of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Individuals: Changing Demographics Over a 6-Year Period
Michael A Moso, Emily Woolnough, Freya Langham, Jennifer F Hoy, Allen C Cheng, Rowan G Walker, Anastasia Chrysostomou, Ian Woolley, Achini Weeraratne, Janine M Trevillyan
Journal article | 2018 | The Journal of Infectious Diseases
Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker
Anastasia Chrysostomou, Eugenia Pedagogos, Lachlan MacGregor, Gavin J Becker
Journal article | 2006 | Clinical Journal of the American Society of Nephrology
Medicine - Royal Melbourne Hospital